Photo by accuray from unsplash
Transcriptomics generates pathogenetic insights not obtainable by histology, but translation of these insights into diagnostic tests is not a trivial task. This opinion‐piece critically appraises declarative MMDx statements, such as… Click to show full abstract
Transcriptomics generates pathogenetic insights not obtainable by histology, but translation of these insights into diagnostic tests is not a trivial task. This opinion‐piece critically appraises declarative MMDx statements, such as the infallibility of machine learning algorithms, measurements of gene expression with >99% precision, and “unambiguous reclassifications” of contentious biopsies such as those with borderline change, polyomavirus nephropathy, chronic active T‐cell or mixed rejection, isolated intimal arteritis, and renal medullary pathology.
Journal Title: Clinical Transplantation
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!